Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study)-Reference-Cited by-同舟云学术

Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study)

Published:2021-05 Issue: Volume:35 Page:100844
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Bertrand Nicolas^ORCID,Guerreschi Pierre,Basset-Seguin Nicole,Saiag Philippe,Dupuy Alain,Dalac-Rat Sophie,Dziwniel Véronique,Depoortère César,Duhamel Alain,Mortier Laurent

Funder

F. Hoffmann-La Roche

F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Basal cell carcinoma: histological classification and body-site distribution;Raasch;Br J Dermatol,2006

2. Frequency of facial basal cell carcinoma does not correlate with site-specific UV exposure;Heckmann;Arch Dermatol,2002

3. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease;McCusker;Eur J Cancer,2014

4. Guidelines of care for the management of basal cell carcinoma;Group;J Am Acad Dermatol,2018

5. Utility of radiotherapy for treatment of basal cell carcinoma: a review;Cho;Br J Dermatol,2014

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in the Management of Advanced Nonmelanoma Skin Cancer;Surgical Oncology Clinics of North America;2024-10

2. Therapeutic Advances in Advanced Basal Cell Carcinoma;Cancers;2024-09-04

3. Surgical Debulking Modifies Notch Signaling and May Improve Vismodegib Effectiveness for Locally Advanced Basal Cell Carcinoma;JID Innovations;2024-09

4. Emerging Indications for Neoadjuvant Systemic Therapies in Cutaneous Malignancies;Medical Sciences;2024-07-23

5. Biomarkers in Cutaneous Keratinocyte Carcinomas;Dermatology and Therapy;2024-07-20